Full-Time
Develops specialized language models for healthcare
No salary listed
Senior
Cleveland, OH, USA
Must be local to the Cleveland area and willing to travel onsite to client locations regularly. In-office sessions in Palo Alto are also required.
Hippocratic AI develops specialized language models designed for healthcare applications. These models are tailored to improve healthcare access, equity, and outcomes by focusing on safety and reliability for non-clinical tasks. The company has created a model that has shown better performance than GPT-4 in numerous healthcare exams, indicating its accuracy and dependability. Hippocratic AI serves hospitals, clinics, and healthcare providers, offering AI solutions that enhance patient care and operational efficiency. Unlike general-purpose AI, Hippocratic AI's models are trained on evidence-based healthcare content and validated through a process that includes feedback from healthcare professionals. The company generates revenue by licensing its models to healthcare institutions and forming partnerships, with a commitment to providing safe and effective AI interactions.
Company Size
51-200
Company Stage
Series B
Total Funding
$276M
Headquarters
Palo Alto, California
Founded
2022
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Flexible Work Hours
Hippocratic AI raised $141 million in a Series B round, totaling over $278 million raised. The startup focuses on AI agents for healthcare, enabling clinicians to create specialized agents for patient care. Andreessen Horowitz (a16z) is a key investor, highlighting its commitment to AI and biotech innovation. The funding will accelerate product development and expand the team. The company collaborates with Stability AI and Story for open-source innovation and blockchain integration.
Hippocratic AI, a generative AI company developing safety-focused large language models for healthcare, has partnered with EUCALIA, a healthcare transformation company, to launch the first Japanese-language genAI healthcare agent for non-diagnostic, patient-facing clinical tasks.
What You Should Know:– Hippocratic AI, the global leader in safety-focused generative AI agents for healthcare, today announced a partnership with EUCALIA Inc., a Tokyo-based healthcare transformation company focused on optimizing clinical operations and advancing care delivery, to launch the first Japanese-language generative AI healthcare agent for non-diagnostic, patient-facing clinical tasks.– This marks Hippocratic AI’s entry into the Japanese market, further advancing its global mission to deliver healthcare abundance through technology.Hippocratic AI and EUCALIA Partner to Launch Japan’s First Safety-Focused Generative AI Healthcare AgentHippocratic AI has partnered with EUCALIA to introduce a generative AI healthcare agent in Japan, designed to enhance patient access and ease clinician workload in a healthcare system facing rising demand, an aging population, and workforce constraints. The agent will handle essential, non-diagnostic, patient-facing responsibilities—including appointment scheduling, medication adherence support, chronic care check-ins, and follow-up outreach—enabling clinicians to focus on core care tasks.At the core of this solution is Hippocratic AI’s Polaris Constellation System, a patented safety-first architecture built specifically for high-empathy, medically accurate conversations. The system has:Powered over 1.85 million patient calls in the U.S.Achieved a clinical accuracy rate of 99.38%Reached a patient experience rating of 8.95/10Been adopted by more than 25 enterprise healthcare partnersThis architecture includes a series of specialized supervisor models that oversee medication discussions, lab results, nutrition, vitals, escalation protocols, and hospital-specific policies—ensuring safe and tailored patient engagement at scale.The collaboration builds on Hippocratic AI’s founding mission to bring healthcare expertise to every human through safe, accessible AI. Co-founded by CEO Munjal Shah alongside clinicians, hospital administrators, and AI experts from institutions like Stanford, Johns Hopkins, Microsoft, and NVIDIA, the company has focused on setting new global standards for clinical AI safety.“This partnership with EUCALIA reflects our commitment to building generative AI agents that are not just multilingual but locally fluent, clinically safe, and culturally aligned,” said Shah. “Together, we aim to deliver meaningful improvements in patient outcomes, clinical operations, and system resilience.”By combining Hippocratic AI’s robust technology with EUCALIA’s local healthcare insight, the partnership aims to create a scalable, culturally competent solution that enhances efficiency, empathy, and accessibility across Japan’s healthcare landscape
Hippocratic AI, the global leader in safety-focused generative AI agents for healthcare, today announced a partnership with EUCALIA Inc., a Tokyo-based healthcare transformation company focused on optimizing clinical operations and advancing care delivery, to launch the first Japanese-language generative AI healthcare agent for non-diagnostic, patient-facing clinical tasks.
Abu Dhabi: Burjeel Holdings today announced a strategic partnership with Hippocratic AI, the company that pioneered the first safety-focused generative AI healthcare agents, to transform healthcare delivery through safe, scalable, and empathetic AI.